Altamira Therapeutics (CYTO) Stock Chart & Stock Price History → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free CYTO Stock Alerts $1.53 +0.06 (+4.08%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Altamira Therapeutics Stock Price Performance5 Day Performance-4.97%1 Month Performance-5.56%3 Month Performance-37.04%6 Month Performance-76.02%Year-To-Date Performance-56.03%1 Year Performance-91.22% Receive CYTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CYTO Stock Chart for Sunday, June, 2, 2024 CYTO Chart by TradingView Altamira Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.47$1.53+4.08%$1.53$1.4849,442 shs$2.32 million05/30/2024$1.60$1.47-8.13%$1.57$1.45154,685 shs$2.32 million05/29/2024$1.61$1.60-0.62%$1.74$1.52136,097 shs$2.53 million05/28/2024$1.78$1.61-9.55%$1.85$1.59559,130 shs$2.54 million05/27/2024$1.78$1.78$1.90$1.63948,700 shs$2.81 million05/24/2024$1.71$1.78+4.09%$1.90$1.63938,481 shs$2.81 million Get the Latest News and Ratings for CYTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.43$1.71+19.58%$2.47$1.6051.56 million shs$2.70 million05/22/2024$1.48$1.43-3.38%$1.52$1.4333,027 shs$2.26 million05/21/2024$1.49$1.48-0.67%$1.51$1.4616,165 shs$2.34 million05/20/2024$1.56$1.49-4.49%$1.53$1.4539,251 shs$2.35 million05/17/2024$1.56$1.56$1.56$1.5120,142 shs$2.47 million05/16/2024$1.53$1.56+1.96%$1.59$1.4525,628 shs$2.47 million05/15/2024$1.44$1.53+6.25%$1.57$1.4355,113 shs$2.42 million05/14/2024$1.48$1.44-2.70%$1.49$1.4240,128 shs$2.28 million05/13/2024$1.45$1.48+2.07%$1.55$1.4050,255 shs$2.34 million05/10/2024$1.50$1.45-3.33%$1.54$1.4030,384 shs$2.29 million05/09/2024$1.47$1.50+2.04%$1.54$1.4342,754 shs$2.37 million05/08/2024$1.58$1.47-6.96%$1.58$1.4480,637 shs$2.32 million05/07/2024$1.65$1.58-4.24%$1.69$1.5554,002 shs$2.50 million05/06/2024$1.64$1.65+0.61%$1.70$1.6136,849 shs$2.60 million05/03/2024$1.62$1.64+1.23%$1.66$1.6029,771 shs$2.59 million05/02/2024$1.62$1.62$1.67$1.5735,179 shs$2.56 million05/01/2024$1.57$1.62+3.18%$1.67$1.53132,722 shs$2.48 million04/30/2024$1.57$1.57$1.60$1.5244,304 shs$2.48 million04/29/2024$1.69$1.57-7.10%$1.69$1.5649,187 shs$2.48 million04/26/2024$1.60$1.69+5.62%$1.77$1.51166,204 shs$2.67 million04/25/2024$1.44$1.60+11.11%$1.65$1.35319,993 shs$2.53 million04/24/2024$1.58$1.44-8.86%$1.60$1.402.99 million shs$2.28 million04/23/2024$1.40$1.58+12.86%$1.58$1.38110,776 shs$2.50 million04/22/2024$1.41$1.40-0.99%$1.52$1.38107,164 shs$2.21 million04/19/2024$1.50$1.41-5.73%$1.50$1.4146,491 shs$2.23 million04/18/2024$1.48$1.50+1.35%$1.52$1.4223,428 shs$2.37 million04/17/2024$1.63$1.48-9.20%$1.65$1.4886,545 shs$2.34 million04/16/2024$1.67$1.63-2.40%$1.73$1.5455,509 shs$2.58 million04/15/2024$1.83$1.67-8.74%$1.88$1.65120,597 shs$2.64 million04/12/2024$1.82$1.83+0.55%$1.94$1.8141,111 shs$2.89 million04/11/2024$2.00$1.82-9.00%$1.97$1.80171,825 shs$2.88 million04/10/2024$1.86$2.00+7.53%$2.00$1.87176,225 shs$3.16 million04/09/2024$1.92$1.86-3.12%$2.03$1.86121,074 shs$2.94 million04/08/2024$1.95$1.92-1.54%$2.01$1.90172,891 shs$3.03 millionWho are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.”04/05/2024$2.09$1.95-6.70%$2.09$1.8679,682 shs$3.08 million04/04/2024$1.94$2.09+7.73%$2.09$1.9392,555 shs$3.30 million04/03/2024$2.05$1.94-5.37%$2.02$1.77169,052 shs$3.07 million04/02/2024$2.11$2.05-2.84%$2.09$1.77112,894 shs$3.24 million04/01/2024$2.07$2.11+1.93%$2.13$1.99114,045 shs$3.33 million03/29/2024$2.07$2.07$2.49$1.96334,107 shs$3.27 million03/28/2024$2.35$2.07-11.91%$2.49$1.96322,567 shs$3.27 million03/27/2024$2.42$2.35-2.89%$2.40$2.22327,601 shs$3.71 million03/26/2024$2.35$2.42+2.98%$2.45$2.171.05 million shs$3.82 million03/25/2024$1.73$2.35+35.84%$3.49$2.1062.76 million shs$3.71 million03/22/2024$1.68$1.72+2.38%$1.73$1.6543,144 shs$2.72 million03/21/2024$1.69$1.68-0.59%$1.69$1.6324,580 shs$2.65 million03/20/2024$1.68$1.69+0.60%$1.72$1.6223,647 shs$2.67 million03/19/2024$1.69$1.68-0.59%$1.74$1.6224,181 shs$2.65 million03/18/2024$1.73$1.69-2.31%$1.73$1.6364,720 shs$2.67 million03/15/2024$1.68$1.73+2.98%$1.73$1.6823,871 shs$2.73 million03/14/2024$1.85$1.68-9.19%$1.82$1.6363,929 shs$2.65 million03/13/2024$1.87$1.85-1.07%$1.95$1.8119,894 shs$2.92 million03/12/2024$1.89$1.87-1.06%$1.90$1.8024,059 shs$2.96 million03/11/2024$1.88$1.89+0.53%$1.92$1.8281,045 shs$2.99 million03/08/2024$1.88$1.88$1.94$1.8230,663 shs$2.97 million03/07/2024$1.86$1.88+1.08%$1.92$1.7652,814 shs$2.97 million03/06/2024$2.02$1.86-7.92%$2.10$1.75244,506 shs$2.94 million03/05/2024$2.37$2.02-14.77%$2.67$2.00712,898 shs$3.19 million03/04/2024$2.43$2.37-2.47%$2.74$2.101.02 million shs$3.75 million03/01/2024$1.88$2.43+29.26%$2.46$1.88729,060 shs$3.84 million Related Companies: SLRX Stock Price Chart ATXI Stock Price Chart LSDI Stock Price Chart CWBR Stock Price Chart NTBL Stock Price Chart CNSP Stock Price Chart CMND Stock Price Chart INM Stock Price Chart AGRX Stock Price Chart GLMD Stock Price Chart Receive CYTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYTO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altamira Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.